| # | Drug | Count |
|---|---|---|
| 0 | EXENATIDE | 9 |
| 1 | ETANERCEPT | 3 |
| 2 | DROSPIRENONE AND ESTRADIOL | 2 |
| 3 | INSULIN GLARGINE | 2 |
| 4 | LEVOTHYROXINE SODIUM | 2 |
| 5 | METFORMIN HCL | 2 |
| 6 | NAPROXEN | 2 |
| 7 | NAPROXEN SODIUM | 2 |
| 8 | ADALIMUMAB | 1 |
| 9 | ADRENALINUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DROSPIRENONE AND ESTRADIOL | 2 | 0.0037 |
| 1 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 | 0.0005 |
| 2 | CALCIUM CHLORIDE INJECTION | 1 | 0.0003 |
| 3 | DEXMETHYLPHENIDATE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | EXENATIDE | 9 | 0.0002 |
| 5 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 1 | 0.0001 |
| 6 | AGALSIDASE BETA | 1 | 0.0001 |
| 7 | BUPIVACAINE | 1 | 0.0001 |
| 8 | MINOCYCLINE | 1 | 0.0001 |
| 9 | BOTULINUM TOXIN TYPE A | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 9 |
| 1 | Estrogen [EPC] | 3 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 4 | Insulin Analog [EPC] | 2 |
| 5 | Progestin [EPC] | 2 |
| 6 | Vitamin C [EPC] | 2 |
| 7 | Acetylcholine Release Inhibitor [EPC] | 1 |
| 8 | Amide Local Anesthetic [EPC] | 1 |
| 9 | Benzodiazepine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Iron Chelator [EPC] | 1 | 0.0000 |
| 3 | GLP-1 Receptor Agonist [EPC] | 9 | 0.0000 |
| 4 | Estrogen [EPC] | 3 | 0.0000 |
| 5 | Catecholamine [EPC] | 1 | 0.0000 |
| 6 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Acetylcholine Release Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Sulfonylurea [EPC] | 1 | 0.0000 |
| 9 | Progestin [EPC] | 2 | 0.0000 |